Intuitive Surgical (NASDAQ:ISRG – Get Free Report) had its target price boosted by stock analysts at BTIG Research from $529.00 to $589.00 in a research note issued on Wednesday, Marketbeat reports. The firm currently has a “buy” rating on the medical equipment provider’s stock. BTIG Research’s price target points to a potential upside of 6.84% from the stock’s previous close.
Several other analysts also recently commented on the company. Wall Street Zen downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday, October 18th. Royal Bank Of Canada restated an “outperform” rating and issued a $615.00 target price on shares of Intuitive Surgical in a research note on Tuesday, August 19th. Truist Financial reduced their target price on Intuitive Surgical from $600.00 to $525.00 and set a “buy” rating for the company in a research note on Wednesday, October 15th. Evercore ISI reduced their target price on Intuitive Surgical from $535.00 to $450.00 and set an “in-line” rating for the company in a research note on Tuesday, October 7th. Finally, Zacks Research downgraded Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 20th. Eighteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $604.50.
Check Out Our Latest Stock Analysis on Intuitive Surgical
Intuitive Surgical Trading Up 4.6%
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last issued its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. The firm had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The business’s revenue was up 22.9% compared to the same quarter last year. During the same period last year, the business posted $1.84 EPS. Equities research analysts forecast that Intuitive Surgical will post 6.43 EPS for the current fiscal year.
Insider Transactions at Intuitive Surgical
In other Intuitive Surgical news, Director Amy L. Ladd sold 336 shares of Intuitive Surgical stock in a transaction dated Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total transaction of $157,956.96. Following the completion of the transaction, the director owned 1,074 shares in the company, valued at approximately $504,898.14. The trade was a 23.83% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the transaction, the insider owned 19,827 shares of the company’s stock, valued at $9,368,059.23. This trade represents a 59.69% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 40,724 shares of company stock valued at $19,500,332 in the last quarter. Company insiders own 0.70% of the company’s stock.
Hedge Funds Weigh In On Intuitive Surgical
Several hedge funds have recently modified their holdings of the company. Brighton Jones LLC raised its holdings in shares of Intuitive Surgical by 24.9% in the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after purchasing an additional 731 shares during the period. GAMMA Investing LLC raised its holdings in shares of Intuitive Surgical by 9.3% in the 1st quarter. GAMMA Investing LLC now owns 6,115 shares of the medical equipment provider’s stock worth $3,029,000 after purchasing an additional 518 shares during the period. Valmark Advisers Inc. raised its holdings in shares of Intuitive Surgical by 8.9% in the 1st quarter. Valmark Advisers Inc. now owns 982 shares of the medical equipment provider’s stock worth $486,000 after purchasing an additional 80 shares during the period. Consolidated Portfolio Review Corp bought a new stake in shares of Intuitive Surgical in the 1st quarter worth approximately $208,000. Finally, International Assets Investment Management LLC raised its holdings in shares of Intuitive Surgical by 14.5% in the 1st quarter. International Assets Investment Management LLC now owns 2,379 shares of the medical equipment provider’s stock worth $1,178,000 after purchasing an additional 301 shares during the period. Institutional investors own 83.64% of the company’s stock.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Articles
- Five stocks we like better than Intuitive Surgical
- What is a Dividend King?
- Warner Bros. Bidding War Potential: How High Could WBD Shares Go?
- Market Cap Calculator: How to Calculate Market Cap
- Analysts Eye 30% Upside in Netflix After Q3 Earnings Crash
- 3 Dividend Kings To Consider
- O’Reilly Automotive’s Stock Price Uptrend Will Continue in 2026
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
